IMMUNODEFICIENCY 47
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Leukopenia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Splenomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cirrhosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent bacterial infection
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
X- linked recessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated hepatic transaminase
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Prolonged neonatal jaundice
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Steatohepatitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased antibody level in blood
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myeloid Leukemia, Chronic
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, a chronic myelogenous leukemia patient who experienced a complete remission after CD4(+) donor lymphocyte infusions also developed high-titer antibodies to ATP6S1.
|
11983866 |
2002 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Three additional vaccinated melanoma patients and three metastatic non-small cell lung carcinoma patients vaccinated with autologous GM-CSF-secreting tumor cells similarly showed a correlation between humoral responses to ATP6S1 and tumor destruction.
|
11983866 |
2002 |
Distal Renal Tubular Acidosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Localization and regulation of the ATP6V0A4 (a4) vacuolar H+-ATPase subunit defective in an inherited form of distal renal tubular acidosis.
|
14638902 |
2003 |
Cutis Laxa
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2.
|
18157129 |
2008 |
IMMUNODEFICIENCY 47
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.
|
27231034 |
2016 |
IMMUNODEFICIENCY 47
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.
|
27231034 |
2016 |
IMMUNODEFICIENCY 47
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.
|
27231034 |
2016 |
Lymphoma, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Large-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Mixed-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |